Venous Ulcers
18
2
2
10
Key Insights
Highlights
Success Rate
77% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
16.7%
3 terminated out of 18 trials
76.9%
-9.6% vs benchmark
0%
0 trials in Phase 3/4
20%
2 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (18)
Multicenter, Randomized, Non-inferiority Study to Compare the Performance and Safety of Debrisoft® Duo With Debrisoft® Pad in the Debridement of Wounds
Study on the Effectiveness of Hypothermal Sulphurous Water in Wound Hygiene
The ROle of Compression StocKings in Heart Failure Patients
HealiAid in the Treatment of Different Wounds
Effect of Compressive Therapies on the Healing of Venous Ulcers
Clinical Implications of Genetic Variations of Venous Stasis Ulceration
Effectiveness of Double-layer Compression Therapy in the Healing of Chronic Venous Ulcers in Primary Health Care
Physical Activity Interventions for Leg Ulcer Patients
Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds
Prospective PuraPly™ AM Case Series Study
Effect of Hyaluronic Acid ECM on Venous Ulcers
Use of Fish Skin Extracellular Matrix (ECM) to Facilitate Chronic Wound Healing
Cooling Lower Leg Skin to Prevent Venous Leg Ulcers in Patients With Poor Vein Circulation
Split Thickness Donor Site Healing With MIST Study
Treatment of Cutaneous Ulcers With a Novel Biological Dressing
Plasma Rich Growth Factors in Venous Ulcers
Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers
Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers